$2.18
At close: Jan 23, 4:00 PM EST
$2.18
N/A
After Hours: 4:18 PM EST
Comments
Loading...
C4 Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:CCCC | Benzinga
C4 Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Feb 26
EPS Estimate
$-0.410
Quarterly Revenue Estimate
$4.61M
Annual Revenue
(as of Sep 30)
(as of Sep 30)
$30.11M
Analyze the earnings history of C4 Therapeutics using advanced sorting and filters.
C4 Therapeutics (CCCC) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-11-06 | $-0.44 | $-0.42 | -4.76 % |
| Q2 | 2025-08-07 | $-0.37 | $-0.38 | 2.63 % |
| Q1 | 2025-05-07 | $-0.37 | $-0.42 | 11.9 % |
| Q4 | 2025-02-27 | $-0.49 | $-0.37 | -32.4 % |
C4 Therapeutics (CCCC) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-11-06 | $11.23M | $6.37M | 76.3 % |
| Q2 | 2025-08-07 | $6.46M | $6.53M | -1.03 % |
| Q1 | 2025-05-07 | $7.24M | $2.95M | 145.4 % |
| Q4 | 2025-02-27 | $5.18M | $3.60M | 43.8 % |
FAQ
When is C4 Therapeutics (NASDAQ:CCCC) reporting earnings?
C4 Therapeutics (CCCC) is scheduled to report earnings on February 26, 2026. The last reported earnings were for reported on November 6, 2025 for Q3.
What were the latest earnings per share (EPS) for C4 Therapeutics (NASDAQ:CCCC)?
The Actual EPS was $-0.44, which missed the estimate of $-0.42.
What were C4 Therapeutics’s (NASDAQ:CCCC) revenues?
The Actual Revenue was $11.2M, which beat the estimate of $6.4M.
Browse earnings estimates, EPS, and revenue on all stocks.
